¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦33Â÷ ´ëÇѳúÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ : 2023-06-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

Á¦33Â÷ ´ëÇѳúÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ : 2023-06-24
±³À°ÀÏÀÚ : 2023-06-24
±³À°Àå¼Ò : ¸ÞÁ¾ ±Û·¡µå Á¦ÁÖÈ£ÅÚ º»°ü1Ãþ ÄÁº¥¼ÇȦ

±³À°ÁÖÁ¦ : Á¦33Â÷ ´ëÇѳúÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѳúÁ¾¾çÇÐȸ
´ã´çÀÚ : ±è¹Ì°æ
¿¬¶ôó : 02-523-6811  

À̸ÞÀÏ : koreabraintumor@gmail.com

±³À°Á¾·ù : ½Å°æ¿Ü°ú

Âü¼®¿¹»óÀÎ : 180¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í Àü¹®ÀÇ 8¸¸¿ø, Àü°øÀÇ 3¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 09:00~09:35 Association between genetic alterations and intraoperative fluorescence activity of 5-aminolevulinic acid in brain metastasis of lung cancer can influence on the local recurrence. ±è¿µÁØ(¼º±Õ°ü´ë »ï¼ºÃ¢¿øº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 09:35~10:10 Noggin contributes to brain metastatic colonization of lung cancer cells ¾ç½ÂÈ£(°¡Å縯´ë ¼ººó¼¾Æ®º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 10:10~11:10 Working towards identifying early events in glioblastomagenesis Kevin Petrecca(Montreal Neurological Institute Hospital, Canada)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 11:30~12:00 Background and Application of AI in Medicine ÀÌ°æÁØ(ºÐ´ç¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 12:00~12:30 Practical Use of AI with an Emphasis on ChatGPT ÁÖÁø´ö(Á¦ÁÖ´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 13:30~14:00 Honored lecture-Legato and andantino À̼±ÀÏ(ÀÎÁ¦´ë ÇØ¿î´ë¹éº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 14:00~14:30 Brain tumor mimicking lesions-Radiology perspective ¹ÚÁöÀº(¿ï»ê´ëÇб³º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 14:30~15:00 Brain tumor mimicking lesions-Neurology perspective ½ÅÇÏ¿µ(¿¬¼¼´ë ¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 15:00~15:30 Brain tumor mimicking lesions-cases presentation Á¤Å¿µ(È­¼øÀü³²´ëº´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 15:50~16:25 Dysregulation of inflammasome activation in glioma ÀÓÀçÁØ(Â÷ÀÇ°úÇÐ´ë ºÐ´çÂ÷º´¿ø)

±³À°½Ã°£ 06¿ù 24ÀÏ ÄÁº¥¼ÇȦ 16:25~17:00 Clinical trial of boron neutron capture therapy for patients with recurred glioblastoma : Phase 1/2a Clinical Trial À̱âÅÃ(°¡Ãµ´ë ±æº´¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦33Â÷ ´ëÇѳúÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ : 2023-06-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023 ÀÌ°úÇÐ ¿¬±¸¼¼¹Ì³ª : 2023-06-24
´ÙÀ½±Û ´ëÇÑÇǺΰúÀÇ»çȸ (2ÀÏÂ÷) Korea Derma 2023 : 2023-06-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 11 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 22 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 121 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 35 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 110 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 30 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 16 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 14 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 40 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 13 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 19 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 8 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 16 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 19 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 19 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷